The divergence between clinical guidelines and practice.
暂无分享,去创建一个
[1] Lippincott Williams Wilkins,et al. ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction , 2004 .
[2] G. Lamas,et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction--executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1999 guidelines for the management of patients wi , 2004, Journal of the American College of Cardiology.
[3] M. Cheitlin. Eplerenone Survival Benefits in Heart Failure Patients Post-Myocardial Infarction Are Independent From its Diuretic and Potassium-Sparing Effects: Insights From an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) Substudy , 2012 .
[4] B. Pitt,et al. Eplerenone, a Selective Aldosterone Blocker, in Patients with Left Ventricular Dysfunction after Myocardial Infarction , 2003 .
[5] A. Hoes,et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. , 2005, European heart journal.
[6] B. Pitt,et al. The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure , 2000 .
[7] C. Yancy,et al. Use of aldosterone antagonists in heart failure. , 2009, JAMA.
[8] Deepak L. Bhatt,et al. Temporal trends and predictors in the use of aldosterone antagonists post-acute myocardial infarction. , 2013, Journal of the American College of Cardiology.
[9] Hani Jneid,et al. 2011 ACCF/AHA focused update incorporated into the ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non-ST-Elevation Myocardial Infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in c , 2011, Journal of the American College of Cardiology.
[10] A. Laupacis,et al. Rates of Hyperkalemia after Publication of the Randomized Aldactone Evaluation Study , 2004 .
[11] B. Thiers,et al. Eligibility Criteria of Randomized Controlled Trials Published in High-Impact General Medical Journals: A Systematic Sampling Review , 2008 .
[12] F. McAlister,et al. Aldosterone blockade and left ventricular dysfunction: a systematic review of randomized clinical trials. , 2008, European heart journal.